SUN PHARMA Surges by 6%; BSE HEALTHCARE Index Up 3.6%

Tue, 24 Mar 12:23 PM

SUN PHARMA share price has zoomed 6% and is presently trading at Rs 347.

Meanwhile, the BSE HEALTHCARE Index is at 11,583 (up 3.6%).

Among the top Gainers in the BSE HEALTHCARE Index today are SUN PHARMA (up 5.8%) and PROCTER & GAMBLE HEALTH (up 6.4%).

FDC LTD. (down 0.9%) and WOCKHARDT (down 1.0%) are among the top losers today.

Over the last one year, SUN PHARMA has moved down from Rs 464 to Rs 347, registering a loss of Rs 117 (down 26.2%).

On the other hand, the BSE HEALTHCARE has moved down from 14,114 to 11,583, loss of 2,531 points (down 19.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 87.4%), IPCA LABS (up 44.4%) and J.B.CHEMICALS (up 37.1%).

Revealed: 3 Stocks for Potentially Massive Gains

What About the Benchmark Indices?

The BSE Sensex is at 27,463 (up 2.3%).

The top gainers among the BSE Sensex stocks today are HUL (up 8.5%), INFOSYS (up 7.5%) and SUN PHARMA (up 5.8%). Other gainers include NESTLE (up 5.7%) and BAJAJ FINANCE (up 5.6%). The most traded stocks in the BSE Sensex are SBI and ONGC.

In the meantime, NSE Nifty is at 8,037 (up 1.9%). The top gainers in the NSE Nifty include BRITANNIA (up 13.4%), ADANI PORTS & SEZ (up 10.6%) and CIPLA (up 8.1%). Other gainers include HUL (up 7.7%) and INFOSYS (up 7.2%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,809 to 27,463, registering a loss of 10,346 points (down 29.69%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 10 billion for the quarter ended December 2019, compared to a loss of Rs 15 billion a year ago. Net Sales rose 5.4% to Rs 81.5 billion during the period as against Rs 77.4 billion in October-December 2018.

For the year ended March 2019, SUN PHARMA reported 25.7% increase in net profit to Rs 44.2 billion compared to net profit of Rs 35.2 billion during FY18.

Revenue of the company grew 9.7% to Rs 291 billion during FY19.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 18.6x.

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftySECTORSAirlinesAluminiumAutomobilesAuto AncillariesBankingCementChemicalsConstructionEnergy SourcesEngineeringFertilizersFMCGFoodInvestment and FinanceMediaPaintPharmaReal EstateShippingSoftwareSteelTelecomTextiles

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers

What else is happening in the markets today? Dig in...